Key points are not available for this paper at this time.
A novel tris(chelate) metalloligand has been used to synthesize a chiral, heterometallic metal-organic framework that is robust to solvent removal and shows selective uptake of nitroaromatic compounds.
Murphy et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: